Avid Bioservices Inc (CDMO)

[biopharm]

Merck knows how Peregrine and the IP assets were always the target

Feng Xu knows exactly what I mean and very interesting ....Rich Richieri found out much about working with what protein pathways were important and all was kept under cover with Rubicon Biotechnology MRI Global etc etc ....so Avid has Rich Richieri back and Roche sidekick Arugadoss Devakumar all of a sudden scheduled for December 3 2019 meetings

Feng Xu .... how far is Merck willing to go ....everyone can't be paid off

All those involved with the Peregrine RNA seq library found out how valuable PS Targeting is...as it allowed for protein characterization to be fully characterized